Quick answer: Vyleesi and PT-141 troches both contain bremelanotide. Vyleesi is an FDA-approved injectable, while PT-141 troches are lozenges that dissolve under the tongue. Because the compounded version of the medication has not been FDA-reviewed, it’s important that you buy it from a trustworthy source like eDrugstore.
A lot of women researching treatment for hypoactive sexual desire disorder (HSDD) land on this exact comparison: Vyleesi, the FDA-approved injection, and PT-141, a compounded troche that dissolves under the tongue. Both rely on the same active ingredient, bremelanotide. But there are differences between them.
Those differences are significant enough that women who choose the PT-141 troche need to be sure they’re buying from a trustworthy source, like eDrugstore.
If needles are part of what’s pushing you toward the troche, or you’re just trying to understand what you’d actually be getting, here’s how the two compare.
Vyleesi vs PT-141 Troche: Same Active Ingredient, Different Products
Vyleesi went through the full FDA approval process, including real clinical trials and a label spelling out exactly how it should be dosed and who it’s for. You can see the details in the FDA prescribing information.
A PT-141 troche is a compounded product, made to order by a compounding pharmacy based on a prescription. Because it’s compounded rather than FDA-approved, where you buy it from matters more than it would for an approved drug, which we’ll get into below.
How Vyleesi (Bremelanotide Injection) Works and What the Clinical Trials Found
How Vyleesi Is Dosed and Administered
Vyleesi works by activating melanocortin receptors, a brain pathway tied to sexual desire. You inject it yourself, under the skin of your abdomen or thigh, at least 45 minutes before you expect to be intimate. The dose is 1.75 milligrams, with a built-in limit of one dose per 24 hours and no more than eight per month.
What the Clinical Trials Showed
That approval came from two large clinical trials in premenopausal women with HSDD. Some women discontinued treatment due to side effects, most commonly nausea. Vyleesi also causes a short-term rise in blood pressure after each dose, so it’s not recommended for women with uncontrolled high blood pressure or known heart disease.
Vyleesi is approved specifically for premenopausal women, not for postmenopausal women or men.
Which Bremelanotide Option Is Right for You
If clinical trial backing and FDA-reviewed manufacturing matter most to you, Vyleesi is the clearer choice, provided you fit the premenopausal HSDD criteria it’s approved for.
If injections are a dealbreaker or you fall outside that approved group, a compounded troche is worth discussing with your health care provider or one of our U.S.-licensed physicians.
Is PT-141 (Compounded Bremelanotide) Cheaper than Vyleesi Injections?
Compounded PT-141 troches cost significantly less per use than Vyleesi injections when you’re paying out of pocket. Even with insurance coverage and manufacturer savings, the cost to eligible patients for four Vyleesi injections is currently $99 through the manufacturer’s savings program, bringing the cost to $24.75 per injection.
PT-141 costs considerably less per dose. Check out eDrugstore’s current price here.
PT-141 vs. Vyleesi Injection: Dosing and Administration Compared
Here’s a quick side-by-side comparison of the two medications:
Is the PT-141 Troche FDA-Approved?
This gets vague warning-label treatment a lot, so let’s walk through the actual mechanics.
How Bremelanotide Qualifies for Compounding
Bremelanotide qualifies for compounding through a specific legal route. The FDA allows compounding of substances that are active ingredients in an already-approved drug, and bremelanotide is the active ingredient in Vyleesi.
That pathway is legitimate, even though bremelanotide doesn’t appear on the FDA’s separate list of substances pre-cleared for compounding.
Why the Troche Form Is a Separate Question
The troche itself hasn’t gone through that same process. Vyleesi is FDA-approved as an injection. Turning that into something you dissolve under your tongue is a different dosage form, and changing the form of an approved drug brings in its own set of rules, including one meant to stop compounding pharmacies from recreating a commercial drug in a different shape without a legitimate reason.
Accepted reasons are usually patient-specific, such as someone who can’t or won’t use needles. Whether a particular troche formulation satisfies that standard is a case-by-case call, not something the FDA has issued a blanket yes to for this category of product.
What This Means for the Evidence Behind the Troche
No clinical trial has tested a sublingual bremelanotide troche, so what we know about bremelanotide’s effects on desire and arousal comes entirely from studies of the injection form of Vyleesi.
Because the FDA doesn’t review compounded products for manufacturing quality, that responsibility falls on the individual compounding pharmacy.
Why Choosing a Trustworthy PT-141 Troche Source Matters
Because the FDA isn’t reviewing this product, the compounding pharmacy is doing the quality-assurance work that would otherwise fall to the agency. Compounding pharmacies vary in how they source and test ingredients, which is why knowing who’s making what you’re taking matters.
Who Manufactures eDrugstore’s Bremelanotide Troche?
eDrugstore’s bremelanotide troche is made by Strive Pharmacy, which reports accreditation from the Pharmacy Compounding Accreditation Board (PCAB) and the National Association of Boards of Pharmacy (NABP). These credentials mean its pharmacy practices have undergone outside review against established quality and safety standards.
Strive’s published quality practices also explain how it checks what goes into its medications: Ingredients come from FDA-registered facilities, and each shipment includes a certificate of analysis documenting its identity and purity. The pharmacy tests randomly selected batches for potency several times a week to confirm the correct amount of active ingredient in each batch.
eDrugstore’s Track Record
eDrugstore itself has operated in Arizona, USA, as a telehealth provider since 1999. We have a 4.8/5-star Trustpilot rating as well as a 4.8/5-star Google Reviews rating across thousands of reviews.
Buy Bremelanotide Online Confidently With eDrugstore
eDrugstore’s licensed providers can help you sort through both options and fill your prescription if PT-141 feels right for you. Learn more about PT-141 troche on our women’s sexual health page and start getting your love life back on track today.
Frequently Asked Questions About PT-141 Troches and Vyleesi
Is a PT-141 Troche the Same Thing as Vyleesi?
They share the same active ingredient, bremelanotide, but Vyleesi is FDA-approved and clinically tested, while the troche is compounded and not subject to FDA review.
Is the PT-141 Troche FDA-Approved?
No. Bremelanotide qualifies for compounding as an ingredient in an already-approved drug, but converting it into a troche is a separate dosage-form question the FDA hasn’t issued a blanket approval for, so the troche itself is not subject to FDA review.
Why Does the Source of a Compounded Troche Matter?
Because the FDA doesn’t review compounded products for manufacturing quality, the pharmacy’s own accreditation and testing practices are one of the best indicators of quality you have.
Does Insurance Cover PT-141 Troches?
Coverage for compounded medications varies and tends to be more limited than for FDA-approved drugs. Check with your provider or insurer.
Disclaimer: This article provides general information about health and related topics but is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Paula Clark worked in the healthcare industry for 17 years before becoming a full-time freelance health and medical writer. Her clients appreciate her ability to convey complex information in terms laypeople can understand. Paula prides herself on the depth and accuracy of her research. Her goal is to add authority to your site in words that will delight both Google and your readers.